| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/23/2008 | CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis |
| 10/23/2008 | CA2678833A1 Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer |
| 10/22/2008 | EP1983055A1 Albumin fusion proteins |
| 10/22/2008 | EP1983001A2 Antibodies to mammalian Langerhans cell antigen and their uses |
| 10/22/2008 | EP1982990A1 Cytokine receptor common gamma chain like |
| 10/22/2008 | EP1982984A2 Tricyclic thrombin receptor antagonists |
| 10/22/2008 | EP1982982A1 Novel coumarin derivative having antitumor activity |
| 10/22/2008 | EP1982732A2 Factor VII or VIIA-like molecules |
| 10/22/2008 | EP1982730A1 Pharmaceutical composition comprising l-carnitine and an antagonist of the membrane adenosine receptors, derivatives and/or pharmaceutically acceptable salts thereof, and their use in the preparation of drugs with non-toxic effect to inhibit the proliferation of neoplastic cells |
| 10/22/2008 | EP1982718A1 Anti-cancer pharmaceutical composition |
| 10/22/2008 | EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents |
| 10/22/2008 | EP1981981A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 10/22/2008 | EP1981890A2 UNSATURATED mTOR INHIBITORS |
| 10/22/2008 | EP1981887A2 Pyrrolo[2,3,b]pyridine derivatives useful as raf kinase inhibitors |
| 10/22/2008 | EP1981886A1 7h-pyridoý3,4-d¨pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors |
| 10/22/2008 | EP1981879A1 Amino indazole derivatives |
| 10/22/2008 | EP1981878A1 Indazole heteroaryl derivatives |
| 10/22/2008 | EP1981877A1 N-hydroxyacrylamide compounds |
| 10/22/2008 | EP1981875A1 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
| 10/22/2008 | EP1981874A1 Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 10/22/2008 | EP1981871A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
| 10/22/2008 | EP1981862A2 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 10/22/2008 | EP1981856A2 Pyrimidine derivatives |
| 10/22/2008 | EP1981850A2 Demethylpenclomedine analogs and their use as anticancer agents |
| 10/22/2008 | EP1981843A2 Vitamin d analog: nel, methods and uses thereof |
| 10/22/2008 | EP1981838A2 Process for synthesis of glycomimicking cationic amphiphiles |
| 10/22/2008 | EP1981539A1 Treatment of metastatic breast cancer |
| 10/22/2008 | EP1981538A2 Metalloproteinase binding proteins |
| 10/22/2008 | EP1981532A2 Epha2 bite molecules and uses thereof |
| 10/22/2008 | EP1981512A1 Modified macromolecule |
| 10/22/2008 | EP1636228B1 Novel pyridopyrazines and use thereof as kinase modulators |
| 10/22/2008 | EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 10/22/2008 | EP1417196B1 Dna-pk inhibitors |
| 10/22/2008 | EP1404349B1 Fat-binding polymers |
| 10/22/2008 | EP1368371B1 Transfection complexes |
| 10/22/2008 | EP1266022B1 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 10/22/2008 | EP1235590B1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 10/22/2008 | EP0787011B1 microemulsion preconcentrate comprising a macrolide |
| 10/22/2008 | CN101292042A Cancerous desease modifying antibodies |
| 10/22/2008 | CN101292041A Cancerous desease modifying antibodies |
| 10/22/2008 | CN101291954A Modified antigen binding molecules with altered cell signaling activity |
| 10/22/2008 | CN101291950A 新系列咪唑基取代的类固醇和茚满-1-酮衍生物 New series of imidazolyl substituted steroidal and indan-1-one derivative |
| 10/22/2008 | CN101291949A Aptamers comprising arabinose modified nucleotides |
| 10/22/2008 | CN101291934A Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| 10/22/2008 | CN101291927A Benzimidazoles useful as inhibitors of protein kinases |
| 10/22/2008 | CN101291926A 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 10/22/2008 | CN101291922A 烷基喹啉和烷基喹唑啉类激酶调节剂 Alkyl quinoline and alkyl quinazoline kinase modulators |
| 10/22/2008 | CN101291680A Antioxidant and Fe2+chelating properties of herbal extracts |
| 10/22/2008 | CN101291675A Novel anticancer concomitant drug |
| 10/22/2008 | CN101289690A Applications of MiR-125b for diagnosing and treating acute myeloid leukemia |
| 10/22/2008 | CN101289653A Nicotine-processed dendritic cells for preventing and treating tumors |
| 10/22/2008 | CN101289511A Multivalent antibodies and uses therefore |
| 10/22/2008 | CN101289510A Anti-CD40 monoclonal antibody |
| 10/22/2008 | CN101289482A Cambogic acid glycoside derivates and the like, preparation and uses thereof |
| 10/22/2008 | CN101289477A N-phenylpropenoyl chitosan oligosaccharide and preparation thereof |
| 10/22/2008 | CN101289468A New oxaliplatin derivate |
| 10/22/2008 | CN101289467A Platinum salts of organic acids, preparation thereof and applications in preparation of anticancer drugs |
| 10/22/2008 | CN101289453A Ellagic acid compounds, preparation thereof and applications in anticancer drugs |
| 10/22/2008 | CN101289452A Process for abstracting camptothecine form nothapodytes |
| 10/22/2008 | CN101289450A Tyrosine phthalocyanines derivates, preparation thereof and applications in preparation of photodynamic drugs |
| 10/22/2008 | CN101289449A 2,6-di-nitrogen-containing substituted purine derivatives, preparation method and applications thereof |
| 10/22/2008 | CN101289445A Aniline quinazoline derivatives, preparation method and uses thereof |
| 10/22/2008 | CN101289444A Pyrimidine derivate and medicinal use thereof |
| 10/22/2008 | CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents |
| 10/22/2008 | CN101289440A Polyene macrocyclic compounds, preparation thereof and applications |
| 10/22/2008 | CN101289421A Method for synthesizing nicotinyl amino acids and sensitizing effect thereof to tumor radiotherapy |
| 10/22/2008 | CN101288773A Complex type transgene lung cancer general tumor vaccine |
| 10/22/2008 | CN101288767A Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method |
| 10/22/2008 | CN101288763A Medicine for treating liver cancer and preparing process thereof |
| 10/22/2008 | CN101288759A Chinese medicinal composition for treating benign thyroid tumor and its preparation method |
| 10/22/2008 | CN101288747A Medicine for treating leukemia |
| 10/22/2008 | CN101288695A Preparation technique of alkaloids from Stephania tetrandra |
| 10/22/2008 | CN101288694A Preparation method of magnolia bark extracts with no residual solvent, low oiliness and high content |
| 10/22/2008 | CN101288682A Microemulsion containing brucea javanica oil and preparation method thereof |
| 10/22/2008 | CN101288681A Preparation technique of ginkgo leaf extract |
| 10/22/2008 | CN101288666A Application of iso-bavachalcone in preparing drug for anti-tumor, anti-osteoporosis and anti-senile dementia |
| 10/22/2008 | CN101288665A Medicine containing alkannin compound as active component |
| 10/22/2008 | CN101288642A Taxanes medicine preparation for intravenous injection and preparation method thereof |
| 10/22/2008 | CN101288475A Production method of flavor panax ginseng |
| 10/22/2008 | CN100427599C ALBSIN/IL-18MAT hybridization cytokine |
| 10/22/2008 | CN100427503C Polypeptide in small molecule of endothelium inhibin, nucleotide sequence for encoding the polypeptide and complementary strand |
| 10/22/2008 | CN100427502C Antineoplastic oligopeptide and its preparation method and application |
| 10/22/2008 | CN100427483C Anthranilic acid amide derivatives and their pharmaceutical use |
| 10/22/2008 | CN100427482C N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof |
| 10/22/2008 | CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof |
| 10/22/2008 | CN100427141C Composition of SOD and animal medicine or its extractives, and its prepn. method |
| 10/22/2008 | CN100427140C Freeze-drying powder injection of Bozhi glycopeptide and its preparation |
| 10/22/2008 | CN100427099C Juglans mandshurica maxim pdysaccharide preparation capable of effectively treating brain cancer and its preapring method |
| 10/22/2008 | CN100427090C Compound prescription of Chinese medicinal effective ingredients having anti-neovascularization synergetic effect |
| 10/22/2008 | CN100427087C Pharmaceutical composition containing oxidized sophoridine or its salt, its preparation method and uses |
| 10/22/2008 | CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 10/22/2008 | CN100427069C Tongkening drip pill used for assistant treating of tumour and its preparation method |
| 10/22/2008 | CN100427068C Kangai drip pill for treating tumour, hepatitis B and its preparation method |
| 10/22/2008 | CN100426996C Anticancer healthy drink of abscisic acid |
| 10/21/2008 | US7439383 Sodium channel blockers |
| 10/21/2008 | US7439362 For treatment of acne, seborrhea, androgenic alopecia. hirsutism, and breast cancer |
| 10/21/2008 | US7439359 Antiproliferative agents; antitumor agents; binding to chaperone protein |
| 10/21/2008 | US7439356 Substituted indan derivatives |
| 10/21/2008 | US7439329 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase |
| 10/21/2008 | US7439320 Cripto tumour polypeptide |